Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6092-6099

  Duddy, Martin ^a   Niino, Masaaki ^a   Adatia, Femina ^a   Hebert, Sherry ^a   Freedman, Mark ^b   Atkins, Harry ^b   Ho, Jin Kim ^a   Bar Or, Amit ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LYMPHOTOXIN; MITOXANTRONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BRAIN DYSFUNCTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EFFECTOR CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO CULTURE; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFER; MALE; MEMORY; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TARGET CELL;

EID: 34248230257     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6092     Document Type: Article

References (52)

1. Lund, F. E., B. A. Garvy, T. D. Randall, and D. P. Harris. 2005. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8: 25-54.
2. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
3. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, and M. B. A. Oldstone. 1998. Evidence for underlying CD4 helper and CD8 T cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from MT/MMT mice. J. Virol. 72: 9208-9216.
4. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918.
5. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163-1168.
6. Chan, O., and M. J. Shlomchik. 1998. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160: 51-59.
7. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1: 147-153.
8. Bar-Or, A., E. M. Oliveira, D. E. Anderson, J. I. Krieger, M. Duddy, and K. C. O'Connor. 2001. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 167: 5669-5677.
9. Shen, H., J. K. Whitmire, X. Fan, D. J. Shedlock, S. M. Kaech, and R. Ahmed. 2003. A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J. Immunol. 170: 1443-1451.
10. Linton, P. J., B. Bautista, E. Biederman, E. S. Bradley, J. Harbertson, R. M. Kondrack, R. C. Padrick, and L. M. Bradley. 2003. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 197: 875-883.
11. O'Neill, S. K., M. J. Shlomchik, T. T. Glant, Y. Cao, P. D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174: 3781-3788.
12. Grimaldi, C. M., R. Hicks, and B. Diamond. 2005. B cell selection and susceptibility to autoimmunity. J. Immunol. 174: 1775-1781.
13. Youinou, P., C. Jamin, J. O. Pers, C. Berthou, A. Saraux, and Y. Renaudineau. 2005. B lymphocytes are required for development and treatment of autoimmune diseases. Ann. NY Acad. Sci. 1050: 19-33.
14. Harris, D. P., S. Goodrich, A. J. Gerth, S. L. Peng, and F. E. Lund. 2005. Regulation of IFN-γ production by B effector 1 cells: essential roles for T-bet and the IFN-γ receptor. J. Immunol. 174: 6781-6790.
15. Harris D. P., S. Goodrich, K. Mohrs, M. Mohrs, and F. E. Lund. 2005. Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor α, and Th2 cells. J. Immunol. 175: 7103-7107.
16. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
17. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL- 10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
18. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
19. Duddy, M. E., A. Alter, and A. Bar-Or. 2004. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172: 3422-3427.
20. Chan, A., F. X. Weilbach, K. V. Toyka, and R. Gold. 2004. Mitoxantrone induces cell death in peripheral blood leukocytes of multiple sclerosis patients. Clin. Exp. Immunol. 139: 152-158.
21. Neuhaus O., H. Wiendl, B. C. Kieseier, J. J. Archelos, B. Hemmer, O. Stüve, and H. P. Hartung. 2005. Multiple sclerosis: mitoxantrone promotes differential effects on immunocompetent cells in vitro. J. Neuroimmunol. 168: 128-137.
22. Poser, C. M., D. W. Paty, L. Scheinberg, W. I. McDonald, F. A. Davis, G. C. Ebers, K. P. Johnson, W. A. Sibley, D. H. Silberberg, and W. W. Tourtellotte. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13: 227-231.
23. Edan, G., D. Miller, M. Clanet, C. Confavreux, O. Lyon-Caen, C. Lubetzki, B. Brochet, I. Berry, Y. Rolland, J. C. Froment, et al. 1997. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomized multicentre study of active disease using MRI and clinical criteria. J. Neurol. Neurosurg. Psychiatry 62: 112-118.
24. Patel, D. D. 2002. B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum. 46: 1984-1985.
25. Monson, N. L., P. D. Cravens, E. M. Frohman, K. Hawker, and M. K. Racke. 2005. Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch. Neurol 62: 258-264.
26. Petereit, H. F., and A. Rubbert. 2005. Effective suppression of cerebrospinal fluid B cells by rituximab and cyclophosphamide in progressive multiple sclerosis. Arch. Neurol. 62: 1641-1642.
27. Stuve, O., S. Cepok, B. Elias, A. Saleh, H. P. Hartung, B. Hemmer, and B. Kieseier. 2005. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch. Neurol. 62: 1620-1623.
28. Cree, B. A., S. Lamb, K. Morgan, A. Chen, E. Waubant, and C. Genain. 2005. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-1272.
29. Alter, A., M. Duddy, S. Hebert, K. Biernacki, A. Prat, J. P. Antel, V. W. Yong, R. K. Nuttall, C. J. Pennington, D. R. Edwards, and A. Bar-Or. 2003. Determinants of human B cell migration across brain endothelial cells. J. Immunol. 170: 4497-4505.
30. Agematsu K., S. Hokibara, H. Nagumo K. Shinozaki, S. Yamada and A. Komiyama. 1999. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk. Lymphoma 35: 219-225.
31. Wang, Y., J. Wang, Y. Sun, Q. Wu, and Y. X. Fu. 2001. Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J. Immunol. 166: 330-337.
32. Baumgarth, N. A. 2000. Two-phase model of B cell activation. Immunol. Rev. 176: 171.
33. Arpin, C., J. Dechanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y. J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268: 720-722.
34. Lipsky, P. 2001. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2: 764-766.
35. Llorente, L., Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B. M. Fourrier, P. Galanaud, and D. Emilie. 1994. In vivo production of IL-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37: 1647-1655.
36. Astier, A. L., G. Meiffren, S. Freeman, and D. A. Hafler. 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116: 3252-3257.
37. Baecher-Allan, C., and D. A. Hafler. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212: 203-216.
38. Cross, A. H., J. L. Trotter, and J. Lyons. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112: 1-14.
39. Prineas, J. W. 1979. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203: 1123-1125.
40. Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi. 2004. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14: 164-174.
41. Corcione, A., S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio, C. Gambini, G. L. Mancardi, A. Uccelli, and V. Pistoia. 2004. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 101: 11064-11069.
42. Uccelli, A., F. Aloisi, and V. Pistoia. 2005. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 26: 254-259.
43. Luther, S. A., T. Lopez, W. Bai, D. Hanahan, and J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12: 471-481.
44. Salmonsson S., M. V. Jonsson, K. Skarstein, K. A. Brokstad, P. Hjelmstrom, M. Wahren-Hernelius, and R. Jonsson. 2003. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 48: 3187-3201.
45. Katakai, T., T. Hara, M. Sugai, H. Gonda, and A. Shimizu. 2003. Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand 13-producing stromal network in chronic lesions of autoimmune gastritis. J. Immunol. 171: 4359-4368.
46. Randen, I., O. J. Mellbye, O. Forre, and J. B. Natvig. 1995. The identification of germinal centers and follicular dendritic cell networks in rheumatoid synovial tissue. Scand. J. Immunol. 41: 481-486.
47. Endres, R., M. B. Alimzhanov, T. Plitz, A. Futterer, M. H. Kosco-Vibois, S. A. Nedospasov, K. Rajewsky, and K. Pfeffer. 1999. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells. J. Exp. Med. 1999: 159-168.
48. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192: 475-482.
49. Gonzalez, M., F. Mackay, J. L. Browning, M. H. Kosco-Vibois, and R. J. Noelle. 1998. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187: 997-1007.
50. Fu, Y. X., G. Huang, Y. Wang, and D. D. Chaplin. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin dependent fashion. J. Exp. Med. 187: 1009-1018.
51. Ngo, V. N., H. Korner, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of spleen. J. Exp. Med. 189: 403-412.
52. Lorenz R. G., D. D. Chaplin, K. G. McDonald, J. S. McDonough, and R. D. Newberry. 2003. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin β receptor and TNF receptor I function. J. Immunol. 170: 5475-5482.